Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study.
Isla S MackenzieIan FordAndrew WalkerChris HawkeyAlan BeggAnthony AveryJaspal TaggarLi WeiAllan D StruthersThomas M MacDonaldnull nullPublished in: BMJ open (2016)
32017426, pre-results.